Zaleplon
Back to searchMolecule Structure
Scientific Name
Zaleplon
Description of the Drug
Zaleplon is a sedative used for short term treatment of insomnia in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00962
http://www.drugbank.ca/drugs/DB00962
Brand Name(s)
Sonata, Zaleplon
Company Owner(s)
Upsher Smith Laboratories Llc, Aurobindo Pharma Ltd, Hikma Pharmaceuticals, Orbion Pharmaceuticals Private Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Unichem Laboratories Ltd, Hikma Pharmaceuticals Usa Inc, Pfizer Inc, Chartwell Molecular Holdings Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA A receptor alpha-1/beta-1/gamma-2 | PROTEIN COMPLEX | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2111392 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL29118 | |
| PharmGKB | PA451952 | |
| Human Metabolome Database | HMDB0015097 | |
| DrugBank | DB00962 | |
| PubChem: Thomson Pharma | 14751928 | |
| PubChem | 5719 | |
| LINCS | LSM-5971 | |
| Nikkaji | J575.185C | |
| BindingDB | 86521 | |
| EPA CompTox Dashboard | DTXSID5023748 | |
| DrugCentral | 2857 | |
| Brenda | 84232 | |
| Guide to Pharmacology | 4345 | |
| rxnorm | SONATA | ZALEPLON |
| PubChem: Drugs of the Future | 12014056 | |
| KEGG Ligand | C07484 | |
| ChEBI | 10102 | |
| ZINC | ZINC000000006300 |
